C14H23BN2O4
294.16 g/mol
의약 중간체경고
Tert-butyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate
CAS552846-17-0EC676-377-6
용도 분류
의약 중간체
화합물 분류
에스터
주요 용도
의약 중간체
This compound is a boron-containing heterocyclic building block used as a pharmaceutical intermediate. It features a pyrazole ring with a tert-butyl ester protecting group and a pinacol boronate ester moiety, which is commonly employed in Suzuki-Miyaura coupling reactions.
pharmaceutical intermediatebuilding block for organic synthesis
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 552846-17-0
관련 화합물
참고동일 카테고리
2-Bromo-6-nitrotoluene
CAS55289-35-5
Pharmaceutical intermediate
참고동일 카테고리
3-Bromo-2-methylaniline
CAS55289-36-6
Pharmaceutical intermediate
참고동일 카테고리
(E)-3-(Dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one
CAS55314-16-4
pharmaceutical intermediate
참고동일 카테고리
5-aminopyridine-2-carbonitrile
CAS55338-73-3
pharmaceutical intermediate
참고same scaffold
1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS827614-69-7
Boronic ester for chemical synthesis
참고same scaffold
1,3,5-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS844891-04-9
Boronic ester synthetic intermediate
참고same scaffold
1,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS1036991-40-8
research reagent
참고same scaffold
1,3-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS1046832-21-6
Boron-containing building block for synthesis
안전 참조
경고
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
식별자
IUPAC 이름
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate
InChIKey
IPISOFJLWYBCAV-UHFFFAOYSA-N
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN(N=C2)C(=O)OC(C)(C)C
동의어 목록 (31)
- Crizotinib Impurity 57